CogState logo

CGS - CogState Share Price

A$0.485 0.0  3.2%

Last Trade - 5:10am

Sector
Healthcare
Size
Micro Cap
Market Cap £32.7m
Enterprise Value £30.6m
Revenue £16.8m
Position in Universe 814th / 1832
Bullish
Bearish
Unlock CGS Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CGS Revenue Unlock CGS Revenue

Net Income

CGS Net Income Unlock CGS Revenue

Normalised EPS

CGS Normalised EPS Unlock CGS Revenue

PE Ratio Range

CGS PE Ratio Range Unlock CGS Revenue

Dividend Yield Range

CGS Dividend Yield Range Unlock CGS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CGS EPS Forecasts Unlock CGS Revenue
Profile Summary

Cogstate Limited is a cognitive science company delivering software and services. The Company's segments include cognitive testing in Clinical Trials; the precision recruitment market, the healthcare market, the sport market and administration. In the clinical trials market, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the precision recruitment market, the technology is used as an online screening tool as part of the process of recruiting subjects in clinical trials. In the healthcare market, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. In the sport market, the technology and associated services are used to provide concussion management tools in sport.

Directors
Last Annual June 30th, 2019
Last Interim June 30th, 2019
Incorporated December 17, 1999
Public Since February 13, 2004
No. of Shareholders: 1,465
No. of Employees: 61
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 135,165,748
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CGS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CGS
Upcoming Events for CGS
Similar to CGS
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.